At a glance

ClinicalIndex Comparison Record

N/ACompleted· 2,169 enrolled

Drug / intervention

MPP +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02832622

NCT02832622N/ACompleted

Compare CT.gov

MultiPoint Pacing™ Post Market Study

Abbott Medical Devices·observational·Posted Jul 14, 2016·Updated Feb 17, 2021

In Brief

An observational study evaluating MPP and BiV/MPP for Heart Failure. Completed, enrolled 2,169 participants across 128 sites in 4 countries.

Detailed Summary

This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsHeart Failure

CountriesArgentina, Colombia, Japan, United States

Collaborators--

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

Enrollment StartJul 2016

First PostedJul 2016

Primary CompletionJul 2019

TodayJul 2026

First PostedJul 14, 2016

Enrollment StartJul 1, 2016

Primary CompletionJul 15, 2019

TodayJul 2, 2026

Enrollment to primary: 3.0 yearsPosted 10.0 years ago

Interventions

MPPdevice

MPP ON within 1 month post implant and then continuously programmed ON until 12 months (i.e., MPP ON for months 1-12 continuously)

BiV/MPPdevice

MPP ON at the 12-month study visit and for at least 3 continuous months prior to 12-month assessment (i.e., BiV pacing ON at some point in months 1-9 and MPP ON for months 10-12)